Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Receivables (2018 - 2025)

Historic Receivables for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to $13.3 million.

  • Dna X's Receivables rose 3950.01% to $13.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.3 million, marking a year-over-year increase of 3950.01%. This contributed to the annual value of $11.5 million for FY2024, which is 5682.25% down from last year.
  • Per Dna X's latest filing, its Receivables stood at $13.3 million for Q3 2025, which was up 3950.01% from $9.8 million recorded in Q2 2025.
  • Over the past 5 years, Dna X's Receivables peaked at $32.0 million during Q3 2023, and registered a low of $5.6 million during Q3 2021.
  • Moreover, its 5-year median value for Receivables was $14.5 million (2024), whereas its average is $16.3 million.
  • Per our database at Business Quant, Dna X's Receivables surged by 26506.64% in 2023 and then plummeted by 7009.82% in 2024.
  • Quarter analysis of 5 years shows Dna X's Receivables stood at $13.1 million in 2021, then surged by 89.17% to $24.7 million in 2022, then increased by 7.43% to $26.5 million in 2023, then crashed by 56.82% to $11.5 million in 2024, then grew by 16.42% to $13.3 million in 2025.
  • Its last three reported values are $13.3 million in Q3 2025, $9.8 million for Q2 2025, and $11.3 million during Q1 2025.